Pfizer : PFE

All Pfizer Articles

1508 Articles

Douglas A. McIntyre | Oct 26, 2011 at 6:28 AM EDT

Shorts Exit Weak Shares (EK, AMR, BP, LVLT)

Short sellers moved out of stocks that have fallen recently. Perhaps they believe there will be a large rally in…

Douglas A. McIntyre | Oct 25, 2011 at 6:24 AM EDT

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work…

Douglas A. McIntyre | Oct 24, 2011 at 6:33 AM EDT

R&D Spenders Get No Respect

A company can spend billions of dollars on R&D and get little respect as an innovator. Even though that is…

Paul Ausick | Oct 20, 2011 at 10:58 AM EDT

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…

Jon C. Ogg | Oct 12, 2011 at 2:10 PM EDT

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…

Jon C. Ogg | Sep 14, 2011 at 1:44 PM EDT

30-Year Auction: 12 of 30 DJIA Stocks Outyield Long Bond (T, CVX, DD, GE, INTC, JNJ, KFT, MRK, PFE, PG, TRV, VZ)

The 30-Year Treasury auction, the so-called Long Bond, had a strong participation for what is technically a 29-year and 11-month…

Jon C. Ogg | Sep 14, 2011 at 8:12 AM EDT

Top Analyst Upgrades & Downgrades (ALKS, AMP, BWA, CSCO, CLB, DD, GTIV, HIG, JASO, JPM, JWN, NSC, ORCL, PFE, STP, TSL, UAL)

Jon OggThese are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…

Jon C. Ogg | Aug 29, 2011 at 12:39 PM EDT

More Than Promising Results for New Heart Drug (BMY, PFE, JNJ, BAYRY, DSKYY, PPH)

A new heart drug aimed a reducing the risk of strokes has outperformed the current drug of choice, warfarin, in…

Douglas A. McIntyre | Aug 29, 2011 at 6:17 AM EDT

Media Digest (8/29/2010) Reuters, WSJ, NYTimes, FT, Bloomberg

LG Display (NYSE: LPL) cuts capital expenditures as demand for LCD screens is hurt by tablet PC sales. (Reuters) Samsung…

Douglas A. McIntyre | Aug 9, 2011 at 8:49 AM EDT

Top Active Trader Alert Stocks (ARMH, GE, JPM, LDK, NOK, PFE, WFC)

Active traders and day traders have many stocks to choose from this Tuesday morning. We are tracking news and moves…

Douglas A. McIntyre | Aug 4, 2011 at 9:26 AM EDT

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability.…

Douglas A. McIntyre | Aug 4, 2011 at 6:21 AM EDT

Media Digest (8/4/2011) Reuters, WSJ, NYT, FT, Bloomberg

Hitachi and Mitsubishi may merge (Reuters) Japan intervened in the yen (Reuters) Spain will offer bonds and the European Central…

Jon C. Ogg | Aug 2, 2011 at 10:01 AM EDT

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY)

Merck & Co. Inc. (NYSE: MRK) released second-quarter results last Friday and Pfizer Inc. (NYSE: PFE) reported this morning. The…

Jon C. Ogg | Jul 29, 2011 at 1:51 PM EDT

Top Earnings Previews For The Week Ahead (CIM, HUM, ADM, COH, DRYS, DUK, OPEN, PFE, SIRI, AWK, CLX, CMCSA, DNDN, GRMN, WFR, TSLA, ZIP, AIG, CVS, DF, FSLR, KFT, LNKD, PCLN, LUV, PG)

We have another very busy earnings week ahead for the second quarter reporting season. Some are DJIA components and some…

Douglas A. McIntyre | Jul 20, 2011 at 6:00 AM EDT

Ten Companies That Will Never Trade At Their All-Time Highs

Some of the best known publicly traded companies in the world have stocks that will never reach their all-time highs…

1 … 80 81 82 83 84 … 101

Pfizer : PFE

All Pfizer Articles

Shorts Exit Weak Shares (EK, AMR, BP, LVLT)

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

R&D Spenders Get No Respect

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

30-Year Auction: 12 of 30 DJIA Stocks Outyield Long Bond (T, CVX, DD, GE, INTC, JNJ, KFT, MRK, PFE, PG, TRV, VZ)

Top Analyst Upgrades & Downgrades (ALKS, AMP, BWA, CSCO, CLB, DD, GTIV, HIG, JASO, JPM, JWN, NSC, ORCL, PFE, STP, TSL, UAL)

More Than Promising Results for New Heart Drug (BMY, PFE, JNJ, BAYRY, DSKYY, PPH)

Media Digest (8/29/2010) Reuters, WSJ, NYTimes, FT, Bloomberg

Top Active Trader Alert Stocks (ARMH, GE, JPM, LDK, NOK, PFE, WFC)

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Media Digest (8/4/2011) Reuters, WSJ, NYT, FT, Bloomberg

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY)

Top Earnings Previews For The Week Ahead (CIM, HUM, ADM, COH, DRYS, DUK, OPEN, PFE, SIRI, AWK, CLX, CMCSA, DNDN, GRMN, WFR, TSLA, ZIP, AIG, CVS, DF, FSLR, KFT, LNKD, PCLN, LUV, PG)

Ten Companies That Will Never Trade At Their All-Time Highs

COPX vs. CPER: Do Copper Miners or Copper Futures Best Play the Electrification Squeeze?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

He Kept His Spouse’s Employer Plan Past 65. Medicare Called It a Gap — and Charged Him for Life.

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

He Kept His Spouse's Employer Plan Past 65. Medicare Called It a Gap — and Charged Him for Life.

COPX vs. CPER: Do Copper Miners or Copper Futures Best Play the Electrification Squeeze?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

Pfizer : PFE

All Pfizer Articles

Shorts Exit Weak Shares (EK, AMR, BP, LVLT)

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

R&D Spenders Get No Respect

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

30-Year Auction: 12 of 30 DJIA Stocks Outyield Long Bond (T, CVX, DD, GE, INTC, JNJ, KFT, MRK, PFE, PG, TRV, VZ)

Top Analyst Upgrades & Downgrades (ALKS, AMP, BWA, CSCO, CLB, DD, GTIV, HIG, JASO, JPM, JWN, NSC, ORCL, PFE, STP, TSL, UAL)

More Than Promising Results for New Heart Drug (BMY, PFE, JNJ, BAYRY, DSKYY, PPH)

Media Digest (8/29/2010) Reuters, WSJ, NYTimes, FT, Bloomberg

Top Active Trader Alert Stocks (ARMH, GE, JPM, LDK, NOK, PFE, WFC)

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Media Digest (8/4/2011) Reuters, WSJ, NYT, FT, Bloomberg

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY)

Top Earnings Previews For The Week Ahead (CIM, HUM, ADM, COH, DRYS, DUK, OPEN, PFE, SIRI, AWK, CLX, CMCSA, DNDN, GRMN, WFR, TSLA, ZIP, AIG, CVS, DF, FSLR, KFT, LNKD, PCLN, LUV, PG)

Ten Companies That Will Never Trade At Their All-Time Highs

COPX vs. CPER: Do Copper Miners or Copper Futures Best Play the Electrification Squeeze?

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

He Kept His Spouse’s Employer Plan Past 65. Medicare Called It a Gap — and Charged Him for Life.

Featured Reads

A Widow Turned Down the Survivor Check at 60 to Protect a Bigger One Later. The Wait Cost Her $50,000.

He Kept His Spouse's Employer Plan Past 65. Medicare Called It a Gap — and Charged Him for Life.